Polar Asset Management Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-117,200
Closed -$5.61M 1315
2022
Q3
$5.61M Buy
+117,200
New +$6.43M 0.07% 441
2022
Q2
Sell
-120,500
Closed -$14M 1413
2022
Q1
$14M Buy
+120,500
New +$14.1M 0.15% 166
2015
Q2
Sell
-29,649
Closed -$3.74M 268
2015
Q1
$3.74M Buy
29,649
+7,952
+37% +$1.03M 0.2% 128
2014
Q4
$2.75M Sell
21,697
-2,913
-12% -$404K 0.15% 133
2014
Q3
$3.3M Buy
+24,610
New +$3.45M 0.17% 117

Other funds holding TNDM

Polar Asset Management Partners's TNDM Position: Q4 2022 in Review

Polar Asset Management Partners sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 117,200 shares — an estimated $5.61M sold.

Polar Asset Management Partners first reported a position in TNDM in Q3 2014 and held it in 5 quarters. The position peaked at $14M in Q1 2022. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Polar Asset Management Partners reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Polar Asset Management Partners sold 117,200 Tandem Diabetes Care shares in Q4 2022, an estimated $5.61M.
  • Polar Asset Management Partners first reported a position in Tandem Diabetes Care in Q3 2014 and held it in 5 quarters.
  • Polar Asset Management Partners's Tandem Diabetes Care position peaked at $14M in Q1 2022.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Polar Asset Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.